FDA Imposes Restrictions on Coast IRB due to Violations The
FDA Imposes Restrictions on Coast IRB due to Violations
The U.S Food and Drug Administration today announced that Coast IRB, LLC of Colorado Springs, Colo., has agreed to voluntarily halt some aspects of its clinical trial oversight operations due to serious concerns about the company's ability to protect human subjects participating in clinical trials.